Funding for this research was provided by:
Cytokinetics, Inc.
Article History
Received: 27 May 2021
Accepted: 26 November 2021
First Online: 25 December 2021
Declarations
:
: Not applicable.
: All authors have approved this manuscript for submission, and claim that none of the material in the paper has been published or is under consideration for publication elsewhere.
: Dr. Piña has received symposium honorarium from Cytokinetics and has no other relationships to disclose. Dr. Allen has consulting relationships with Johnson and Johnson/Janssen, Novartis, Boston Scientific, Amgen/Cytokinetics, and ACI Clinical and has received grant funding from the American Heart Association, the National Institutes of Health, and the Patient-Centered Outcomes Research Institute. Dr. Desai has received symposium honorarium from Cytokinetics and support from the Centers for Medicare and Medicaid Services to develop and maintain performance measures that are used for public reporting and payment programs; Blue Cross Blue Shield Association to develop novel methods to improve the process of evidence generation; and Johnson and Johnson to develop a platform to share clinical trial data; he has served as a consultant for Anthem, Amgen, Boehringer Ingelheim, Cytokinetics, Novartis, and Relypsa.